HBV is a common infection that accounts for hundreds of thousands of deaths each year, despite the availability of a vaccine. A new study has evaluated the Chinese neonatal vaccination programme and found that the vaccine considerably reduces the incidence of liver diseases, and that a booster vaccine might be effective.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Lavanchy, D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J. Viral Hepat. 11, 97–107 (2004).
World Health Organization. Hepatitis B [online], (2014).
McMahon, B. J. et al. Acute hepatitis B virus infection: relation of age to the clinical expression of disease and subsequent development of the carriers state. J. Infect. Dis. 151, 599–603 (1985).
[No authors listed] Hepatitis B vaccines [French]. Wkly Epidemiol. Rec. 28, 255–263 (2004).
Huang, K. & Lin, S. Nationwide vaccination: a success story in Taiwan. Vaccine 18 (Suppl. 1), S35–S38 (2000).
Chang, M. H. et al. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group. N. Engl. J. Med. 336, 1855–1859 (1997).
McMahon, B. J. et al. Elimination of hepatocellular carcinoma and acute hepatitis B in children 25 years after a hepatitis B newborn and catch-up immunization program. Hepatology 54, 801–807 (2011).
Qu, C. et al. Efficacy of neonatal HBV vaccination on liver cancer and other liver diseases over 30-year follow-up of the Qidong Hepatitis B intervention study: a cluster randomized controlled trial. PLoS Med. http://dx.doi.org/10.1371/journal.pmed.1001774.
Chakvetadze, C. et al. Efficacy of hepatitis B sero-vaccination in newborns of African HBsAg positive mothers. Vaccine 29, 2846–2849 (2011).
Soleimani Amiri, M. J., Hasanjani Roushan, M. R., Baiany, M., Taheri, H. & Hasanjani Roushan, M. Outcomes of passive-active immunoprophylaxis given to infants of mothers infected with hepatitis B virus in Babol, Iran. J. Clin. Virol. 49, 283–285 (2010).
Acknowledgements
S.P. would like to acknowledge the help of W. Gerlich in preparing this manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Pol, S. HBV vaccine—the first vaccine to prevent cancer. Nat Rev Gastroenterol Hepatol 12, 190–191 (2015). https://doi.org/10.1038/nrgastro.2015.28
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrgastro.2015.28
This article is cited by
-
Neonatal hepatitis B vaccination protects mature adults from occult virus infection
Hepatology International (2021)